LCTX
Lineage Cell Therapeutics, Inc.Healthcare$1.57
◆ Neutral
Mkt Cap: $391.1M|Float: 187.1M|SI: 13.6%|DTC: 23.3
Data as of market close Apr 2, 2026
IV Rank
22
IV Pctl
22%
HV 20d
58.5%
52W Range
$0-$2
ATR(14)
$0.09
Exp. Move
±20.7%
P/C Ratio
0.05
Earnings
May 12
GEX Positive
DEX Long
Net Put Premium
IV Low
Max Pain Below
Exp. Move Wide
Low Put/Call
LCTX Key Options Data
- IV Rank
- 21.5%
- Total GEX
- $0.00B
- Total DEX
- $0.3M
- Max Pain
- $1.50
- Expected Move
- ±20.7%
- Put/Call OI
- 0.05
- Net Premium
- $-0.0M
- Spot Price
- $1.57
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$0.33 | ±20.7% | $1.25 | $1.90 |
| 2026-06-18 | 77 | ±$0.68 | ±43.0% | $0.90 | $2.25 |
| 2026-09-18 | 169 | ±$1.30 | ±82.8% | $0.27 | $2.87 |
Explore LCTX options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.